Robert Joyce

Robert Joyce

Multiple Sclerosis (MS) and Asthma Patient Stories

Robert Joyce has lived with multiple sclerosis (MS) for more than 25 years. He writes Life Effects articles for MS and asthma.

  • Living With Condition: 26 Years
  • Location: Connemara, Ireland

About Robert Joyce

He started a blog in 2017 after being diagnosed with secondary progressive MS. Since then, Robert has become an active patient advocate, often spreading awareness of the condition on Facebook and Twitter.

Recently, Robert has been working with PARADIGM as a patient representative. He's currently an assistant researcher for a new study on MS-related cognitive problems and their treatment. 

History of the Condition

Robert was diagnosed with relapsing-remitting MS at 23. He had a 10-year dormant period but relapsed after a car accident in 2014. The trauma resulted in chronic headaches, which have not stopped since.

Robert also lives with asthma, sarcoidosis (a rare condition causing small patches of red, swollen tissue to develop in his organs), and erythema nodosum (swollen fatty tissue under the skin).


Articles By Robert Joyce


Disclaimer & Legal Notice

© 2023 Life Effects by Teva Pharmaceuticals

The individual(s) who have written and created the content in and whose images appear in the articles, profiles, podcasts and videos on the Life Effects website have been paid by Teva Pharmaceuticals for their contributions. This content represents the opinions of the contributor and does not necessarily reflect those of Teva Pharmaceuticals. Similarly, Teva Pharmaceuticals does not review, control, influence or endorse any content related to the contributor's websites or social media networks. All content on the Life Effects pages are intended for informational and educational purposes and should not be considered medical advice or recommendations. Consult a qualified medical professional for diagnosis and before beginning or changing any treatment regimen.

This site is intended for UK and Ireland residents only.

Date of preparation: March 2024
D: COB-GB-NP-00453 (V1.0) / T: COB-GB-NP-00451 (V1.0) / M: COB-GB-NP-00452 (V1.0)